Katherine Stueland, Chief Executive Officer at GeneDx Holdings Corp. (WGS), sold 19,179 shares at $90.68 ($1.7M) on 2025-07-01, disclosed to the SEC on 2025-07-03.
Scheduled sale ($1.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.68 | 6,928 | $628K | 36.0% |
| 2 | $90.68 | 6,928 | $628K | 36.0% |
| 3 | $91.55 | 2,594 | $237K | 13.6% |
| 4 | $91.55 | 2,594 | $237K | 13.6% |
| 5 | $92.46 | 135 | $12K | 0.7% |
| Total | $90.93 avg | 19,179 |
| $1.7M |
| 100% |
| Filing → |
| WGS | SELL | 2026-06-18 | $638K | — | Filing → |
| WGS | SELL | 2026-06-11 | $196K | — | Filing → |
| WGS | SELL | 2026-05-01 | $142K | — | Filing → |